Creso Pharma
Creso Pharma Ltd (ASX:CPH, FRA:1X8 OTCMKTS:COPHF) brings the best of cannabis to better the lives of people and animals.
See more information about Creso Pharma
Creso Pharma makes strategic changes to pursue near-term growth and commercialisation
Creso Pharma Ltd (ASX:CPH) (OTCMKTS:COPHF) has made several strategic board and management changes aimed at strengthening its position in pursuit of several important near-term growth initiatives and commercialisation efforts.
Creso co-founder and chief executive officer Dr Miri Halperin Wernli will transition to the role of technology, innovation and distribution head and continue to serve on the company's board of directors.
This transitioning will allow Dr Halperin Wernli to focus on new technologies for the hemp and cannabis products globally as well as furthering the commercialisation and distribution efforts of the Mernova medical cannabis products.
"Important commercialisation phase"
Given Dr Halperin Wernli's considerable experience and strong track record of delivering key milestones, the company believes the move will allow her to aggressively pursue several near-term initiatives in Europe and Canada.
Creso non-executive chairman Adam Blumenthal said: "Firstly, I would like to take this opportunity to thank and congratulate Miri on her dedication and numerous achievements during her time as CEO.
"Miri has been instrumental in the development and international expansion of Creso Pharma's human and animal health business, and we look forward to her continued input and leadership as the various divisions enter an important commercialisation phase."
Other Creso Pharma news
- Creso Pharma set to benefit as regulatory shifts on cannabis and broadened global footprint underpin growth
2021-02-05 - Creso Pharma to explore near-term US opportunities after lawmakers take first step to decriminalise cannabis on national level
2020-12-07 - Creso Pharma secures first retail order from Nova Scotia provincial government’s distributor NLSC
2020-09-21 - Creso Pharma welcomes TGA reclassification of CBD for Australian markets
2020-09-10 - Creso Pharma Canadian subsidiary ramps up cannabis production ahead of premium retail product launch
2020-06-24
